Furthermore, APE1 redox function was also shown to confer 5-FU resistance in colon cancer because treatment with APE1 redox inhibitor E3330 enhanced tumor response to 5-FU in a colon cancer xenograft model (54). Here, APEX1 is linked to malignant colon neoplasm.